BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9607556)

  • 1. Hereditary prostate cancer and other genetic predispositions to prostate cancer.
    Cussenot O; Valeri A; Berthon P; Fournier G; Mangin P
    Urol Int; 1998; 60 Suppl 2():30-4; discussion 35. PubMed ID: 9607556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in genetic susceptibility to prostate cancer.
    Cussenot O; Valeri A
    Eur J Intern Med; 2001 Feb; 12(1):11-16. PubMed ID: 11173005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada.
    Gong G; Oakley-Girvan I; Wu AH; Kolonel LN; John EM; West DW; Felberg A; Gallagher RP; Whittemore AS
    Cancer Causes Control; 2002 Jun; 13(5):471-82. PubMed ID: 12146852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of familial prostatic cancer: 4-year assessment of French studies].
    Valeri A; Drelon E; Azzouzi R; Delannoy A; Teillac P; Fournier G; Mangin P; Berthon P; Cussenot O
    Prog Urol; 1999 Sep; 9(4):672-9. PubMed ID: 10555220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial aggregation of prostate cancer in African-Americans and white Americans.
    Cunningham GR; Ashton CM; Annegers JF; Souchek J; Klima M; Miles B
    Prostate; 2003 Sep; 56(4):256-62. PubMed ID: 12858353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic, epidemiologic and clinical study of familial prostate cancer].
    Valéri A
    Bull Acad Natl Med; 2002; 186(4):779-88; discussion 788-91. PubMed ID: 12412374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic susceptibility to prostate cancer].
    Cussenot O; Cancel-Tassin G
    Med Sci (Paris); 2004 May; 20(5):562-8. PubMed ID: 15190476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.
    Wu AH; Whittemore AS; Kolonel LN; John EM; Gallagher RP; West DW; Hankin J; Teh CZ; Dreon DM; Paffenbarger RS
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):735-41. PubMed ID: 8672990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predisposition to prostate cancer: possible explanations for ethnic differences in risk.
    Shibata A; Whittemore AS
    Prostate; 1997 Jun; 32(1):65-72. PubMed ID: 9207959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians.
    Kimura T
    Chin J Cancer; 2012 Sep; 31(9):421-9. PubMed ID: 22085526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer genetics.
    Cancel-Tassin G; Cussenot O
    Minerva Urol Nefrol; 2005 Dec; 57(4):289-300. PubMed ID: 16247350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence.
    Valeri A; Briollais L; Azzouzi R; Fournier G; Mangin P; Berthon P; Cussenot O; Demenais F
    Ann Hum Genet; 2003 Mar; 67(Pt 2):125-37. PubMed ID: 12675688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):31-41. PubMed ID: 20184087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic and racial differences in prostate cancer incidence and mortality.
    Farkas A; Marcella S; Rhoads GG
    Ethn Dis; 2000; 10(1):69-75. PubMed ID: 10764132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men.
    Platz EA; Pollak MN; Rimm EB; Majeed N; Tao Y; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1107-10. PubMed ID: 10613344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men.
    Wu AH; Whittemore AS; Kolonel LN; Stanczyk FZ; John EM; Gallagher RP; West DW
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):533-8. PubMed ID: 11352865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspective: prostate cancer susceptibility genes.
    Simard J; Dumont M; Soucy P; Labrie F
    Endocrinology; 2002 Jun; 143(6):2029-40. PubMed ID: 12021166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
    Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
    Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.
    Reichardt JK; Makridakis N; Henderson BE; Yu MC; Pike MC; Ross RK
    Cancer Res; 1995 Sep; 55(18):3973-5. PubMed ID: 7664265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.